Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer

International Journal of Cancer

Volumn 74, Issue 1, 1997, Pages 64-68

  Volm, Manfred ^a   Koomägi, Reet ^a   Mattern, Juergen ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LIFE TABLES; LUNG NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; SURVIVAL RATE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 1842328560     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970220)74:1<64::AID-IJC11>3.0.CO;2-I     Document Type: Article

References (20)

1. BYAR, D.P., Analysis of survival data: Cox and Weibull models with covariates. In: V. Mike and K.E. Stanley (eds.), Statistics in medical research. Methods and issues with application in cancer research, pp. 365-401, J. Wiley, New York (1982).
2. CARR, D.T. and MOUNTAIN, C.F. Staging lung cancer. In: M.J. Strauss (ed.), Lung cancer. Clinical diagnosis and treatment, pp. 151-161, Grune & Stratton, New York (1977).
3. DIONNE, C.A., CRUMLEY, G., BELLOT, F., KAPLOW, J.M., SEARFOSS, G., RUTA, M., BURGESS, W.H., JAYE, M. and SCHLESSINGER, J., Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J., 9, 2685-2692 (1990).
4. EFFERTH, T. and VOLM, M., Immunocytochemical detection of oncoproteins in animal and human tumor lines with acquired or inherent multidrug resistance. Cancer Detect. Prevent., 16, 237-243 (1992).
5. FERRARA, N., HOUCK, K., JAKEMAN, L. and LEUNG, D.W., Molecular and biological properties of the vascular endothelial-growth-factor family of proteins. Endocrine Rev., 13, 8-32 (1992).
6. FLEISS, J.L. (ED.), STATISTICAL METHODS FOR RATES AND PROPORTION. J. WILEY, NEW YORK (1973).
7. FOLKMAN, J., Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285, 1182-1186 (1971).
8. KAPLAN, E.L. and MEIER, P., Nonparametric estimation from incomplete observations. J. Amer. Statist. Assoc., 53, 457-481 (1956).
9. KIM, K.J., Li, B., WINER, J., ARMANINI, M., GILLET, N., PHILLIPS, H.S. and FERRARA, N., Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.), 362, 841-844 (1993).
10. KOLCH, W., MARTINY-BARON, G., KIESER, A. and MARME, D., Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res. Treat., 36, 139-155 (1995).
11. MAEDA, K., CHUNG, Y.S., OGAWA, Y., TAKATSUKA, S., KANG, S.-M., OGAWA, M., SAWADA, T. and SOWA, M., Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer, 77, 858-863 (1996).
12. SHWEIKI, D., ITIN, A., SOFTER, D. and KESHET, E., Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359, 843-845 (1992).
13. TERMAN, B.I., CARRION, M.E., KOVACS, E., RASMUSSEN, B.A., EDDY, R.L. and SHOWS, T.B., Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene. 6, 519-524 (1991).
14. TOI, M., HOSHINA, S., TAKAYANAGI, T. and TOMINAGA, T., Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn. J. Cancer Res., 85, 1045-1049 (1994).
15. VOLM, M., BAK, M., EFFERTH, T., LATHAN, B. and MATTERN, J., Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4. Anticancer Res., 8, 531-536 (1988).
16. VOLM, M., MATTERN, J. and SAMSEL, B., Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein, and glutathione S-transferase-π in human lung tumors. Cancer. 71, 3181-3187 (1993).
17. VOLM, M., MATTERN, J., STAMMLER, G., ROYER-POKORA, B., SCHNEIDER, S., WEIRICH, A. and LUDWIG, R., Expression of resistance-related proteins in nephroblastoma after chemotherapy. Int. J. Cancer. 63, 193-197 (1995).
18. WEIDNER, N., Intratumor microvessel density as a prognostic factor in cancer. Amer. Pathol., 147, 9-19(1995).
19. WORLD HEALTH ORGANIZATION. Histological typing of lung tumors. Tumori. 6, 253-272 (1981).
20. YAMANE, A., IKADA, T., TOJO, T., MATSUSHIME, H. and SATO, M., Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) closely rolated to the fms family. Oncogene. 8, 519-527 (1990).